Sensidose is a pharmaceutical company. The company has developed a system for individualized dosing of tablets, a medical treatment using a dosing device pre-programmed for the patient. The company's product portfolio includes a number of brands and drugs intended for the treatment of, for example, Parkinson's. The main operations are in the Nordic region.

Quotes for Sensidose Aktiebolag

Right Now

+/-
0.17
%
5,11%
Latest
3.5
High
3.5
Low
3.2
Volume
13 277
Turnover (SEK)
45 573
Market Value (MSEK)
41,9
Time (Latest trade)

Board

CEO

  • Jack Spira

Chairperson of the Board

  • Per Nilsson

Board

  • Jack Spira
  • Lasse Tenerz
  • Sten-Magnus Aquilonius

Largest Owners

Name Capital % Votes % Date
BWG Invest Sàrl (William Gunnarsson) 11,61 11,61 2022-05-12
Per Vasilis 9,52 9,52 2022-05-12
Lars-Åke Adolfsson 7,88 7,88 2022-05-12
Jungfrutomten Värdeinvest Aktiebolag 6,82 6,82 2022-05-12
Gerhard Dal 4,59 4,59 2022-05-12
Per Nilsson 4,40 4,40 2022-05-11
Christer Nyström 3,86 3,86 2022-05-12
Yvonne Håkansson 3,86 3,86 2022-05-12
Sten-Magnus Aquilonius 2,32 2,32 2022-05-12
Håkan Englund 2,16 2,16 2022-05-12
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2022-08-18 Delårsrapport 2022-Q2

  • 2022-11-10 Delårsrapport 2022-Q3

  • 2023-02-16 Bokslutskommuniké 2022